GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Bluemtec Co Ltd (XKRX:439580) » Definitions » Intrinsic Value: Projected FCF

Bluemtec Co (XKRX:439580) Intrinsic Value: Projected FCF : ₩0.00 (As of Jun. 20, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Bluemtec Co Intrinsic Value: Projected FCF?

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.

As of today (2024-06-20), Bluemtec Co's Intrinsic Value: Projected FCF is ₩0.00. The stock price of Bluemtec Co is ₩11930.00. Therefore, Bluemtec Co's Price-to-Intrinsic-Value-Projected-FCF of today is 0.0.

The historical rank and industry rank for Bluemtec Co's Intrinsic Value: Projected FCF or its related term are showing as below:

XKRX:439580's Price-to-Projected-FCF is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 1.25
* Ranked among companies with meaningful Price-to-Projected-FCF only.

Bluemtec Co Intrinsic Value: Projected FCF Historical Data

The historical data trend for Bluemtec Co's Intrinsic Value: Projected FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bluemtec Co Intrinsic Value: Projected FCF Chart

Bluemtec Co Annual Data
Trend Dec20 Dec21 Dec22
Intrinsic Value: Projected FCF
- - -

Bluemtec Co Quarterly Data
Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Intrinsic Value: Projected FCF Get a 7-Day Free Trial - - - - -

Competitive Comparison of Bluemtec Co's Intrinsic Value: Projected FCF

For the Pharmaceutical Retailers subindustry, Bluemtec Co's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bluemtec Co's Price-to-Projected-FCF Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Bluemtec Co's Price-to-Projected-FCF distribution charts can be found below:

* The bar in red indicates where Bluemtec Co's Price-to-Projected-FCF falls into.



Bluemtec Co Intrinsic Value: Projected FCF Calculation

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.

The details of how we calculate the intrinsic value of stocks are described in detail here.

This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + 0.8 * Total Stockholders Equity (most recent) ) / Shares Outstanding (Diluted Average)

In the case of negative Total Stockholders Equity, the following formula is used (see Explanation section below for the reason):

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + Total Stockholders Equity (most recent) / 0.8 ) / Shares Outstanding (Diluted Average)



Bluemtec Co  (XKRX:439580) Intrinsic Value: Projected FCF Explanation

The growth multiple is capped between 8.35 and 17.74.

Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.

Bluemtec Co's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as

Price-to-Intrinsic-Value-Projected-FCF=Share Price/Intrinsic Value: Projected FCF
=11930.00/
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bluemtec Co Intrinsic Value: Projected FCF Related Terms

Thank you for viewing the detailed overview of Bluemtec Co's Intrinsic Value: Projected FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Bluemtec Co (XKRX:439580) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
No. 322-2, 322-2A, 184, Jungbu-daero, Giheung-gu , Gyeonggi-do, 1612, 1613, 1614, 1615 Yeongdeok-dong, Hicks U Tower, Yongin-si, KOR
Bluemtec Co Ltd is a company whose main business is selling prescription drugs through an e-commerce platform. It operates two pharmaceutical distribution platforms, BluePharmKorea targeting hospitals and clinics, and KoolPharm targeting pharmacies and provide IT services to operate and advance these two platforms. In addition, they are operating BlueLabs, which provides services and website development for pharmaceutical companies and medical institutions.

Bluemtec Co (XKRX:439580) Headlines

No Headlines